Dyne Therapeutics is focused on delivering functional improvement for people living with genetically driven neuromuscular diseases. We are developing therapeutics that target muscle and the central nervous system (CNS) to address the root cause of disease. The company is advancing clinical programs for Duchenne muscular dystrophy (DMD) and myotonic dystrophy type 1 (DM1) as well as preclinical programs for facioscapulohumeral muscular dystrophy (FSHD), Pompe disease and multiple DMD mutations. At Dyne, we are on a mission to deliver functional improvement for individuals, families and communities. Learn more at https://www.dyne-tx.com/, and follow us on X, LinkedIn and Facebook.
The Executive Director, TechOps Alliance and Strategic Partnerships shapes and leads the strategy, governance, and performance of key external partnerships that enable successful manufacturing, technical operations, development, and supply activities. This role serves as a senior enterprise partner, aligning internal and external stakeholders, anticipating risks and opportunities, and establishing the operating mechanisms required to deliver commitments across the product lifecycle. The role applies deep alliance-management and biopharmaceutical expertise to strengthen partner accountability, support informed executive decisions, and advance Dyne’s strategic and operational objectives.